• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝细胞癌切除术后死亡率预测风险评分的建立与验证。

Development and validation of a risk score for predicting mortality after resection of primary hepatocellular carcinoma.

机构信息

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

Aging (Albany NY). 2020 Jun 21;12(12):11878-11892. doi: 10.18632/aging.103360.

DOI:10.18632/aging.103360
PMID:32568098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7343477/
Abstract

BACKGROUND

Primary hepatocellular carcinoma (PHCC) has a poor prognosis and high short-term mortality rate, even after resection. Thus, early diagnosis in PHCC cases can help improve quality of life via personalized management strategies.

RESULTS

The risk score system (RSS) were classified as low risk (<5 points), medium risk (5-10 points), or high risk (>10 points). The areas under the receiver operating characteristic curves were 0.80 in the training cohort and 0.69 in the validation cohort, which indicated satisfactory prognostic performance. The Hosmer-Lemeshow goodness of fit test (>0.05) revealed consistent performance in both groups. The concordance index (C-index: 0.663, 95% CI: 0.618-0.708) revealed excellent discrimination and good calibration in the validation cohort.

CONCLUSIONS

This simple RSS, which is based on clinical and laboratory data from patients undergoing resection of PHCC, might allow clinicians and medical staff to better manage PHCC.

MATERIALS AND METHODS

A total of 672 PHCC cases were retrospectively obtained from the First Affiliated Hospital of Wenzhou Medical University between January 2007 and February 2015. Cox proportional hazard models were used to identify independent predictors of mortality. Kaplan-Meier curves and the log-rank test were used to examine the relationships between the prognostic factors and overall mortality.

摘要

背景

原发性肝细胞癌(PHCC)预后差,短期死亡率高,即使在切除后也是如此。因此,PHCC 病例的早期诊断可以通过个性化管理策略来提高生活质量。

结果

风险评分系统(RSS)分为低危(<5 分)、中危(5-10 分)或高危(>10 分)。训练队列的受试者工作特征曲线下面积为 0.80,验证队列为 0.69,表明预后表现良好。Hosmer-Lemeshow 拟合优度检验(>0.05)表明两组均具有一致的性能。一致性指数(C 指数:0.663,95%CI:0.618-0.708)在验证队列中显示出良好的区分度和校准度。

结论

该 RSS 基于接受 PHCC 切除术的患者的临床和实验室数据,可能使临床医生和医务人员能够更好地管理 PHCC。

材料和方法

回顾性收集 2007 年 1 月至 2015 年 2 月温州医科大学第一附属医院 672 例 PHCC 病例。Cox 比例风险模型用于确定死亡率的独立预测因素。Kaplan-Meier 曲线和对数秩检验用于检验预后因素与总死亡率之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/7fecea05a27b/aging-12-103360-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/0bd4fb38c49c/aging-12-103360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/5de01b0360ec/aging-12-103360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/3efd789480e5/aging-12-103360-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/7fecea05a27b/aging-12-103360-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/0bd4fb38c49c/aging-12-103360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/5de01b0360ec/aging-12-103360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/3efd789480e5/aging-12-103360-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7b/7343477/7fecea05a27b/aging-12-103360-g004.jpg

相似文献

1
Development and validation of a risk score for predicting mortality after resection of primary hepatocellular carcinoma.原发性肝细胞癌切除术后死亡率预测风险评分的建立与验证。
Aging (Albany NY). 2020 Jun 21;12(12):11878-11892. doi: 10.18632/aging.103360.
2
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
3
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.HALT-HCC 评分的开发和验证:用于预测肝癌肝移植受者死亡率的回顾性队列分析。
Lancet Gastroenterol Hepatol. 2017 Aug;2(8):595-603. doi: 10.1016/S2468-1253(17)30106-1. Epub 2017 May 22.
4
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
5
Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.用于术前评估接受根治性切除的巴塞罗那临床肝癌分期A1期以上肝细胞癌患者长期生存情况的列线图。
Oncotarget. 2016 Sep 20;7(38):61378-61389. doi: 10.18632/oncotarget.11358.
6
Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best?预测肝细胞癌肝切除术后早期死亡率的不同临床风险评分:哪一个是最佳的?
ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. Epub 2019 Aug 6.
7
Prognostic Nomograms for Pre- and Postoperative Predictions of Long-Term Survival for Patients Who Underwent Liver Resection for Huge Hepatocellular Carcinoma.接受巨大肝细胞癌肝切除术患者长期生存术前和术后预测的预后列线图
J Am Coll Surg. 2015 Nov;221(5):962-974.e4. doi: 10.1016/j.jamcollsurg.2015.08.003. Epub 2015 Aug 10.
8
Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.用于预测肝细胞癌根治性肝切除术后复发和生存的预后列线图。
Ann Surg. 2015 May;261(5):939-46. doi: 10.1097/SLA.0000000000000747.
9
Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.非侵入性纤维化标志物与肝癌肝切除术后术后死亡率的关系。
JAMA Netw Open. 2019 Jan 4;2(1):e187142. doi: 10.1001/jamanetworkopen.2018.7142.
10
Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.血小板计数及基于血小板的模型对肝细胞癌复发的意义
World J Gastroenterol. 2015 May 14;21(18):5607-21. doi: 10.3748/wjg.v21.i18.5607.

本文引用的文献

1
Use of a novel index, the A-index, and its associated nomogram to predict overall survival rates after resection of primary hepatocellular carcinoma.使用一种新的指数,即 A 指数及其相关的列线图,来预测原发性肝细胞癌切除术后的总生存率。
Clin Chim Acta. 2020 Jan;500:34-41. doi: 10.1016/j.cca.2019.10.001. Epub 2019 Oct 23.
2
Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.美国肝脏成像报告和数据系统 2017 版在肝细胞癌高危患者中的验证。
Radiology. 2019 Aug;292(2):390-397. doi: 10.1148/radiol.2019190035. Epub 2019 Jun 18.
3
Hepatic arterial chemotherapy for hepatocellular carcinoma.
Lancet Oncol. 2019 Jun;20(6):e301. doi: 10.1016/S1470-2045(19)30343-2. Epub 2019 May 16.
4
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.NIACE 评分通过巴塞罗那临床肝癌分期细化了肝细胞癌的总生存率。
J Gastroenterol Hepatol. 2019 Dec;34(12):2179-2186. doi: 10.1111/jgh.14705. Epub 2019 Jun 18.
5
Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.复发性肝细胞癌的外科治疗:实现长期生存。
Ann Surg. 2021 Apr 1;273(4):792-799. doi: 10.1097/SLA.0000000000003358.
6
Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus.经颈静脉肝内门体分流术联合碘-125植入治疗门静脉主干肿瘤血栓
World J Gastrointest Oncol. 2019 Apr 15;11(4):310-321. doi: 10.4251/wjgo.v11.i4.310.
7
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.SHON 表达可预测蒽环类联合化疗或他莫昔芬治疗后乳腺癌患者的反应和复发风险。
Br J Cancer. 2019 Apr;120(7):728-745. doi: 10.1038/s41416-019-0405-x. Epub 2019 Feb 28.
8
A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.通过S指数建立的预测原发性肝细胞癌根治性切除术后总生存期的样本模型。
Cancer Manag Res. 2019 Jan 14;11:693-703. doi: 10.2147/CMAR.S193593. eCollection 2019.
9
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.甲胎蛋白阴性肝细胞癌预后列线图的建立与验证。
Int J Biol Sci. 2019 Jan 1;15(1):221-228. doi: 10.7150/ijbs.28720. eCollection 2019.
10
A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.基于单个肿瘤>7cm 和多个肿瘤超出 up-to-seven 标准的改良早期和中期肝细胞癌分期。
Aliment Pharmacol Ther. 2019 Jan;49(2):202-210. doi: 10.1111/apt.15074. Epub 2018 Dec 2.